Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential

Adam Roberts(Cleveland Clinic), Xiaodong Gu(Cleveland Clinic), Jennifer A. Buffa(Cleveland Clinic), Alex G. Hurd(Cleveland Clinic), Zeneng Wang(Cleveland Clinic), Weifei Zhu(Cleveland Clinic), Nilaksh Gupta(Cleveland Clinic), Sarah M. Skye(Cleveland Clinic), David B. Cody(Procter & Gamble (United States)), Bruce S. Levison(Cleveland Clinic Lerner College of Medicine), William Barrington(University of California, Los Angeles), Matthew W. Russell(Cleveland Clinic), Jodie M. Reed(Procter & Gamble (United States)), Ashraf Duzan(Cleveland State University), Jennifer M. Lang(University of California, Los Angeles), Xiaoming Fu(Cleveland Clinic), Lin Li(Cleveland Clinic), Alex J. Myers(Cleveland Clinic Lerner College of Medicine), Suguna Rachakonda(Cleveland Clinic), Joseph A. DiDonato(Cleveland Clinic), J. Mark Brown(Cleveland Clinic), Valentin Gogonea(Cleveland State University), Aldons J. Lusis(University of California, Los Angeles), José Carlos Garcı́a-Garcı́a(Procter & Gamble (United States)), Stanley L. Hazen(Cleveland Clinic)
Nature Medicine
July 26, 2018
Cited by 544

Abstract


Related Papers

No related papers found

Powered by citation graph analysis